ARCHIVES

FDA Approves Tamoxifen For “Reduction In Incidence,” Avoids Word “Prevention”

This article is from The Cancer Letter archive.

Vol. 24 No. 42 | November 6, 1998

Download PDF Visit The Full Archive

Related Articles

ASCO honors physicians for clinical trials participation.

June 4, 2004

Phase II Study Of Pfizer Drug Meets Primary Endpoint

April 24, 2009

In Brief: DeVita Receives Griffuel Prize; Commission On Ethics To Take Up Compensation Question

December 12, 1980

Black Women More Likely To Delay Diagnosis, Treatment

July 29, 2005

Board Commends M.D. Anderson On 50th Year

May 17, 1991

Cooperative Groups: Committee Formed To Implement Armitage Report Had A Rough Start

June 12, 1998